1 / 16

Fetal Growth Restriction: Definition, Risk Factors, Screening, and Management

Learn about fetal growth restriction, including its definition and risk factors. Discover screening methods and management techniques for both near-term and remote-term cases. Additionally, explore the risk factors and management options for macrosomia.

gradyt
Download Presentation

Fetal Growth Restriction: Definition, Risk Factors, Screening, and Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 태아발육이상

  2. Fetal Growth Restriction

  3. Definition • Low birthweight • 출생체중이 2,500 그램 미만 • High birthweight (Macrosomia) • 출생체중이 4,000 그램 이상 • SGA(small-for-gestational-age) • 10th percentile 미만의 출생체중 • 주산기 예후가 나쁜 경우는 대부분 3 percentile 미만

  4. Definition • Symmetrical • Malformation, infection, severe maternal malnutrition, smoking • Asymmetrical • Placental insufficiency or poor uteroplacental perfusion • “Brain sparing" effect

  5. Risk Factors • Constitutionally small mothers • Poor maternal weight gain and nutrition • Social deprivation • Fetal infection • Rubella, cytomegalovirus, hepatitis A, B, toxoplasmosis, syphilis • Congenital malformations • Chromosomal abnormalities

  6. Risk Factors • Primary disorders of cartilage and bone • Osteogenesis imperfecta • Chondrodystrophy • Vascular disease • Chronic vascular disease with superimposed preeclampsia • Chronic renal disease • Chronic hypoxia • High altitude, cyanotic heart disease

  7. Risk Factors • Maternal anemia • Sickle cell disease • Placental and cord abnormalities • Multiple fetuses • Extrauterine pregnancy • Chemical teratogens • Tobacco, narcotics, alcohol • Some anticonvulsants

  8. Screening & Identification • Uterine fundal height • Safe, simple, inexpensive, reasonable screening method • 40 % detection rate • Inability to differentiate between symmetrical & asymmetrical G. R. • 18th-30th wks : fundal height in cm ≒ weeks of gestation

  9. Screening & Identification • 초음파 검사 • 임신 16-20주: 임신주수 확인, 선천성 기형 확인 • 임신 32-34주: 태아발육지연 확인 • Abdominal circumference • Ductus venosus level에서 측정 • 태아발육지연의 most reliable index

  10. Screening & Identification • 초음파 검사 • Amniotic fluid volume • Fetal hypoxia  Reduced renal blood flow by redistribution  Diminished urine output  Oligohydramnios • Oligohydramnios: highly suggestive of fetal growth failure

  11. Screening & Identification • Doppler Velocimetry • Fetal hypoxia  Redistribution of blood flow  Increased peripheral vascular resistance • Umbilical artery S/D ratio 증가 • Diastolic flow 소실 또는 reversed diastole

  12. Management • Near term • Prompt delivery • Severe oligohydramnios • 34주 이상이면 분만시킴

  13. Management • Remote from term • Hospitalization & Decrease physical activity, Adequate diet • Meticulous search for etiology • Monitor with fetal surveillance test • 살 수 있을 만큼 충분히 성숙되었으나 심한 발육지연이 있는 경우  빨리 분만시켜 신생아 치료를 잘하는 것이 예후에 좋다

  14. Macrosomia

  15. Risk Factors • Large parents, especially obese mother • Multiparity • Prolonged gestation • Maternal age • Male fetus • Previous macrosomia • Race and ethnicity

  16. Prognosis & Management • Prognosis • Shoulder dystocia • Cesarean delivery • Management • Prophylactic labor induction • Not recommended • Elective cesarean delivery • Diabetic mother with estimated fetal weights exceeding 4250 g

More Related